Evans' syndrome following autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
A 34-year-old woman with non-Hodgkin's lymphoma received high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation (PBSCT). She developed Evans' syndrome, the association of immune thrombocytopenia and autoimmune hemolytic anemia, 49 days after transplantation. Multiple autoimmune disorders may occur concurrently after autologous PBSCT.
Kamezaki
K
K
Internal Medicine, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan. kamezaki@pa2.so-net.ne.jp
Fukuda
T
T
Makino
S
S
Harada
M
M
D000328:Adult; D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy / Q000209:etiology*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000150:complications / Q000628:therapy*; D036102:Peripheral Blood Stem Cell Transplantation / Q000009:adverse effects*; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy / Q000209:etiology*; D012008:Recurrence; D012074:Remission Induction; D013577:Syndrome; D014182:Transplantation, Autologous